<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-CRI-2029</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2029</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Рецептор CD32а и его роль в норме и при патологии</article-title><trans-title-group xml:lang="en"><trans-title>CD32a receptor in health and disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арсентьева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Arsentieva</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Арсентьева Наталья Александровна – к.б.н., старший научный сотрудник</p><p>197101, Санкт-Петербург, ул. Мира, 14.Teл.: 8 (904) 646-57-58.</p></bio><bio xml:lang="en"><p>Arsentieva Natalia A. – PhD (Biology), Senior Research Associate</p><p>197101, St. Petersburg, Mira str., 14.Phone: 7 (904) 646-57-58.</p></bio><email xlink:type="simple">arsentieva_n.a@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бацунов</surname><given-names>О. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Batsunov</surname><given-names>O. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера»; старший лаборант кафедры иммунологии ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Junior Research Associate, Pasteur Research Institute of Epidemiology and Microbiology; Senior Laboratory Assistant, Department of Immunology, Pavlov University</p><p>St. Petersburg</p></bio><email xlink:type="simple">batsunov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., доцент кафедры иммунологии ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ; заведующий отделом иммунологии ФГБНУ «Институт экспериментальной медицины»</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD (Biology), Assistant Professor, Department of Immunology, First St. Petersburg State I. Pavlov Medical University; Head, Department of Immunology, Institute of Experimental Medicine</p><p>St. Petersburg</p></bio><email xlink:type="simple">igorek1981@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семёнов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.б.н., заместитель директора по инновационной работе ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера»; профессор кафедры иммунологии ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Biology), Deputy Director for Innovation, Pasteur Research Institute of Epidemiology and Microbiology; Professor, Department of Immunology, First St. Petersburg State I. Pavlov Medical University</p><p>St. Petersburg</p></bio><email xlink:type="simple">alexvsemenov@yahoo.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тотолян</surname><given-names>Арег А.</given-names></name><name name-style="western" xml:lang="en"><surname>Totolian</surname><given-names>Areg A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН, директор ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера»; заведующий кафедрой иммунологии ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Director, Pasteur Research Institute of Epidemiology and Microbiology; Head, Department of Immunology, First St. Petersburg State I. Pavlov Medical University</p><p>St. Petersburg</p></bio><email xlink:type="simple">totolian@spbraaci.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pasteur Research Institute of Epidemiology and Microbiology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера»; ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pasteur Research Institute of Epidemiology and Microbiology; First St. Petersburg State I. Pavlov Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ; ФГБНУ «Институт экспериментальной медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First St. Petersburg State I. Pavlov Medical University; Institute of Experimental Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2020</year></pub-date><volume>22</volume><issue>3</issue><fpage>433</fpage><lpage>442</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Арсентьева Н.А., Бацунов О.К., Кудрявцев И.В., Семёнов А.В., Тотолян А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Арсентьева Н.А., Бацунов О.К., Кудрявцев И.В., Семёнов А.В., Тотолян А.А.</copyright-holder><copyright-holder xml:lang="en">Arsentieva N.A., Batsunov O.K., Kudryavtsev I.V., Semenov A.V., Totolian A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2029">https://www.mimmun.ru/mimmun/article/view/2029</self-uri><abstract><p>Низкоаффинные Fcγ-рецепторы, ответственные за распознавание Fc-фрагмента молекул иммуноглобулинов (Ig), обычно в связанном с антигеном состоянии, являются связующим звеном между врожденным и гуморальным иммунитетом. Они играют значимую роль при воспалительных и инфекционных заболеваниях. Среди них выделяют отдельное семейство FcγRII (СD32), особенностью которого является передача внутриклеточного сигнала независимо от общей γ-цепи, они имеют одну α-цепь, содержащую 2 внеклеточных иммуноглобулиноподобных домена. Рецепторы FcγRII представлены практически на всех клетках врожденного иммунитета: моноцитах и макрофагах, нейтрофилах, эозинофилах, дендритных клетках, а также В-лимфоцитах и тромбоцитах. Они выполняют две основные функции: обеспечивают распознавание, облегчают фагоцитоз и разрушение моноцитами/макрофагами опсонизированных антителами клеток (в том числе патогенных); параллельно происходит активация фагоцитов, путем стимуляции синтеза цитокинов. Среди членов FcγRII семейства присутствуют активационные FcγRIIA (CD32a) и FcγRIIC (CD32c) и ингибирующие FcγRIIB (CD32b) рецепторы. Рецепторы FcγRII с низкой аффинностью связываются с IgG, естественными лигандами для них являются иммунные комплексы. Высокие уровни иммунных комплексов обычно обнаруживаются как при хронических вирусных инфекциях, так и при аутоиммунных заболеваниях. Известны полиморфные варианты гена CD32а, которые могут приводить к изменению функции рецептора и, тем самым обуславливать различную восприимчивость к инфекциям, влиять на развитие аутоиммунных заболеваний и первичных иммунодефицитных состояний. Активация рецептора CD32a индуцирует выработку провоспалительных цитокинов, включая TNFα и интерферонов, которые участвуют в воспалении при системной красной волчанке, болезни Кавасаки, болезни Грейвса и ревматоидном артрите. Показано, что посредством рецептора CD32a осуществляется антибактериальная активность тромбоцитов. Особый интерес вызвало исследование экспрессии CD32a у людей, инфицированных вирусом иммунодефицита человека (ВИЧ). Рецептор CD32a претендует на роль биомаркера клеток, являющихся резервуаром ВИЧ-инфекции. Однако на сегодняшний день остается много вопросов относительно механизмов экспрессии CD32a на ВИЧ-инфицированных клетках и роли CD32a в формировании резервуара ВИЧ и/или развития резистентности. Помимо ВИЧинфекции, показано значение рецепторов FcγR в других инфекционных заболеваниях, например при инфекции, вызванной вирусом гриппа и лихорадки денге. Лучшее понимание структуры и функции этого рецептора поможет оценить его роль в иммунопатогенезе заболеваний. Настоящий обзор сосредоточен на роли CD32a в развитии иммунного ответа в норме и при различных заболеваниях.</p></abstract><trans-abstract xml:lang="en"><p>Low-affinity Fcγ-receptors that recognize the Fc portion of immunoglobulin (Ig) molecules, usually being in antigen-bound state, thus representing a link between innate and adaptive immunity. They play a significant role in inflammatory and infectious diseases. Among them, a separate FcγRII family (CD32) is discerned, which is characterized by transmission of intracellular signal independently of the common γ-chain, they have one α-chain containing two extracellular immunoglobulin-like domains. FcγRII receptors are present in almost all cells of the innate immune system: monocytes and macrophages, neutrophils, eosinophils, dendritic cells, as well as on B-lymphocytes and platelets. They perform two main functions: target recognition, facilitation of phagocytosis and destruction of antibody-opsonized cells by monocytes/ macrophages (including pathogenic cells). In parallel, the phagocytes are activated via the cytokine synthesis stimulation. The FcγRIIA (CD32a) and FcγRIIC (CD32c) activating receptors, like as FcγRIIB (CD32b) inhibiting receptors are present among the members of the FcγRII family. The low-affinity FcγRII receptors bind to IgG, with immune complexes being their natural ligands. High levels of immune complexes are usually found in both chronic viral infections and autoimmune diseases. There are shown polymorphic variants of the CD32a gene, which can affect the receptor function, and, thereby, causing susceptibility for different infections, influence the development of autoimmune diseases and primary immunodeficiencies. Activation of the CD32a receptor induces the production of pro-inflammatory cytokines, including TNFα and interferons, that are involved into inflammation in systemic lupus erythematosus, Kawasaki disease, Graves’ disease and rheumatoid arthritis. It has been shown that antibacterial activity of platelets is carried out via the CD32a receptor. The study of CD32a expression in people The CD32a receptor is considered a biomarker of cells that are a reservoir of HIV infection. At the present time, however, many questions remain regarding the mechanisms of CD32a expression of on HIV-infected cells and the role of CD32a in the formation of an HIV reservoir and/or development of appropriate resistance. In addition to HIV infection, the significance of FcγR receptors is shown in other infectious diseases, for example, with influenza and dengue virus infections. Better understanding of the CD32a structure and function will help to assess its role in immunopathogenesis of different conditions. This review focuses on the role of CD32a in development of the normal immune response in normal state and various diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>CD32a</kwd><kwd>FcγRIIA</kwd><kwd>Fcγ-рецептор</kwd><kwd>инфекции</kwd><kwd>ВИЧ-инфекция</kwd><kwd>аутоиммунные заболевания</kwd><kwd>рак</kwd></kwd-group><kwd-group xml:lang="en"><kwd>CD32a</kwd><kwd>FcγRIIA</kwd><kwd>Fcγ-receptor</kwd><kwd>infection</kwd><kwd>HIV infection</kwd><kwd>autoimmunity</kwd><kwd>cancer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Арсентьева Н.А., Бацунов О.К., Семенов А.В., Тотолян А.А. Экспрессия молекулы CD32а на Т-лимфоцитах пациентов, инфицированных ВИЧ // Материалы научно-практических конференций в рамках V Российского конгресса лабораторной медицины (РКЛМ 2019), 2019. С. 130.</mixed-citation><mixed-citation xml:lang="en">Arsentieva N.A., Batsunov O.K., Semenov A.V., Totolyan A.A. Expression of the CD32a molecule on T lymphocytes of HIV-infected patients. Materials of scientific and practical conferences within the framework of the V Russian Congress of Laboratory Medicine (RСLM 2019), 2019, р. 130.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Серебряная Н.Б., Шанин С.Н., Фомичева Е.Е., Якуцени П.П. Тромбоциты как активаторы и регуляторы воспалительных и иммунных реакций. Часть 2. Тромбоциты как участники иммунных реакций // Медицинская иммунология, 2019. T. 21, № 1. С. 9-20. doi: 10.15789/1563-0625-2019-1-9-20.</mixed-citation><mixed-citation xml:lang="en">Serebryanaya N.B., Shanin S.N., Fomicheva E.E., Yakutseni P.P. Blood platelets as activators and regulators of inflammatory and immune reactions. Part 2. Thrombocytes as participants of immune reactions. Meditsinskaya Immunologiya = Medical Immunology (Russia), 2019, Vol. 21, no. 1, pp. 9-20. (In Russ.) doi: 10.15789/1563-0625-2019-1-9-20.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Серебряная Н.Б., Якуцени П.П., Климко Н.Н. Роль тромбоцитов в патогенезе бактериальных инфекций // Журнал инфектологии, 2017. Т. 9, № 4. С. 5-13.</mixed-citation><mixed-citation xml:lang="en">Serebryanaya N.B., Yakutseni P.P., Klimko N.N. The role of platelets in the pathogenesis of bacterial infections. Zhurnal infektologii = Journal of Infectology, 2017, Vol. 9, no. 4, pp. 5-13. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин А.А. Иммунология: учебник. М.: ГЭОТАР-Медиа, 2010. 752 с.</mixed-citation><mixed-citation xml:lang="en">Yarilin A.A. Immunology: textbook. Moscow: GEOTAR-Media, 2010. 752 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Astier A., de la Salle H., de la Salle C., Bieber T., Esposito-Farese M.E., Freund M., Cazenave J.P., Fridman W.H., Teillaud J.L., Hanau D. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J. Immunol., 1994, Vol. 152, no. 1, pp. 201-212.</mixed-citation><mixed-citation xml:lang="en">Astier A., de la Salle H., de la Salle C., Bieber T., Esposito-Farese M.E., Freund M., Cazenave J.P., Fridman W.H., Teillaud J.L., Hanau D. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J. Immunol., 1994, Vol. 152, no. 1, pp. 201-212.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Abdel-Mohsen M., Kuri-Cervantes L., Grau-Exposito J., Spivak A.M., Nell R.A., Tomescu C., Vadrevu S.K., Giron L.B., Serra-Peinado C., Genesca M., Castellvi J., Wu G., Del Rio Estrada P.M., Gonzalez-Navarro M., Lynn K., King C.T., Vemula S., Cox K., Wan Y., Li Q., Mounzer8, Jay Kostman K., Frank I., Paiardini M., Hazuda D., ReyesTeran G., Richman D., Howell B., Tebas P., Martinez-Picado J., Planelles V., Buzon M.J., Betts M.R., Montaneret L.G. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci. Transl. Med., 2018, Vol. 10, no. 437, pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.</mixed-citation><mixed-citation xml:lang="en">Abdel-Mohsen M., Kuri-Cervantes L., Grau-Exposito J., Spivak A.M., Nell R.A., Tomescu C., Vadrevu S.K., Giron L.B., Serra-Peinado C., Genesca M., Castellvi J., Wu G., Del Rio Estrada P.M., Gonzalez-Navarro M., Lynn K., King C.T., Vemula S., Cox K., Wan Y., Li Q., Mounzer8, Jay Kostman K., Frank I., Paiardini M., Hazuda D., ReyesTeran G., Richman D., Howell B., Tebas P., Martinez-Picado J., Planelles V., Buzon M.J., Betts M.R., Montaneret L.G. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci. Transl. Med., 2018, Vol. 10, no. 437, pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arsentieva N.A., Batsunov O.K., Semenov A.V., Kudriavtsev I.V., Esaulenko E.V., Boeva E.V., Kovelenov A.Yu., Totolian A.A. Expression of CD32a receptor on T helper cells in peripheral blood of HIV-infected patients. Immunologic Research (in press).</mixed-citation><mixed-citation xml:lang="en">Arsentieva N.A., Batsunov O.K., Semenov A.V., Kudriavtsev I.V., Esaulenko E.V., Boeva E.V., Kovelenov A.Yu., Totolian A.A. Expression of CD32a receptor on T helper cells in peripheral blood of HIV-infected patients. Immunologic Research (in press).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bave U., Magnusson M., Eloranta M.L., Perers A., Alm G.V., Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus Ig. J Immunol G., 2003, Vol. 171, no. 6, pp. 3296-3302.</mixed-citation><mixed-citation xml:lang="en">Bave U., Magnusson M., Eloranta M.L., Perers A., Alm G.V., Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus Ig. J Immunol G., 2003, Vol. 171, no. 6, pp. 3296-3302.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Boilard E., Pare G., Rousseau M., Cloutier N., Dubuc I., Levesque T., Borgeat P., Flamand L. Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation. Blood, 2014, Vol. 123, no. 18, pp. 2854-2863.</mixed-citation><mixed-citation xml:lang="en">Boilard E., Pare G., Rousseau M., Cloutier N., Dubuc I., Levesque T., Borgeat P., Flamand L. Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation. Blood, 2014, Vol. 123, no. 18, pp. 2854-2863.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Boonnak K., Slike B.M., Donofrio G.C., Marovich M.A. Human FcgammaRII cytoplasmic domains differentially influence antibodymediated dengue virus infection. J. Immunol., 2013, Vol. 190, no. 11, pp. 5659-5665.</mixed-citation><mixed-citation xml:lang="en">Boonnak K., Slike B.M., Donofrio G.C., Marovich M.A. Human FcgammaRII cytoplasmic domains differentially influence antibodymediated dengue virus infection. J. Immunol., 2013, Vol. 190, no. 11, pp. 5659-5665.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest., 2005, Vol. 115, no. 10, pp. 2914-2923.</mixed-citation><mixed-citation xml:lang="en">Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest., 2005, Vol. 115, no. 10, pp. 2914-2923.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Brooks D.G., Qiu W.Q., Luster A.D., Ravetch J.V. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med., 1989, Vol. 170, no. 4, pp. 1369-1385.</mixed-citation><mixed-citation xml:lang="en">Brooks D.G., Qiu W.Q., Luster A.D., Ravetch J.V. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med., 1989, Vol. 170, no. 4, pp. 1369-1385.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brouwer K.C., Lal A.A., Mirel L.B., Otieno J., Ayisi J., van Eijk A.M. Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya. J. Infect. Dis., 2004, Vol. 190, no. 6, pp. 1192-1198.</mixed-citation><mixed-citation xml:lang="en">Brouwer K.C., Lal A.A., Mirel L.B., Otieno J., Ayisi J., van Eijk A.M. Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya. J. Infect. Dis., 2004, Vol. 190, no. 6, pp. 1192-1198.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Brouwer K.C., Lal R.B., Mirel L.B., Yang C., van Eijk A.M., Ayisi J. Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS, 2004, Vol. 18, no. 8, pp. 1187-1194.</mixed-citation><mixed-citation xml:lang="en">Brouwer K.C., Lal R.B., Mirel L.B., Yang C., van Eijk A.M., Ayisi J. Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS, 2004, Vol. 18, no. 8, pp. 1187-1194.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., Daeron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood, 2009, Vol. 113, no. 16, pp. 3716-3725.</mixed-citation><mixed-citation xml:lang="en">Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., Daeron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood, 2009, Vol. 113, no. 16, pp. 3716-3725.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Canobbio I., Stefanini L., Guidetti G.F., Balduini C., Torti M. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation. Cell Signal., 2006, Vol. 18, no. 6, pp. 861-870.</mixed-citation><mixed-citation xml:lang="en">Canobbio I., Stefanini L., Guidetti G.F., Balduini C., Torti M. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation. Cell Signal., 2006, Vol. 18, no. 6, pp. 861-870.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Clawson C.C., White J.G. Platelet interaction with bacteria. II. Fate of the bacteria. Am. J. Pathol., 1971, Vol. 65, no. 2, pp. 381-397.</mixed-citation><mixed-citation xml:lang="en">Clawson C.C., White J.G. Platelet interaction with bacteria. II. Fate of the bacteria. Am. J. Pathol., 1971, Vol. 65, no. 2, pp. 381-397.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Darcis G., Berkhout B., Pasternak A.O. The quest for cellular markers of HIV reservoirs: any color you like. Front. Immunol., 2019, Vol. 10, 2251. doi: 10.3389/fimmu.2019.02251.</mixed-citation><mixed-citation xml:lang="en">Darcis G., Berkhout B., Pasternak A.O. The quest for cellular markers of HIV reservoirs: any color you like. Front. Immunol., 2019, Vol. 10, 2251. doi: 10.3389/fimmu.2019.02251.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Descours B., Petitjean G., Lopez-Zaragoza J.L., Bruel T., Raffel R., Psomas C., Reynes J., Lacabaratz C., Levy Y., Schwartz O., Lelievre J.D., Benkirane M. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication competent proviruses. Nature, 2017, Vol. 543, no. 7646, pp. 564-567.</mixed-citation><mixed-citation xml:lang="en">Descours B., Petitjean G., Lopez-Zaragoza J.L., Bruel T., Raffel R., Psomas C., Reynes J., Lacabaratz C., Levy Y., Schwartz O., Lelievre J.D., Benkirane M. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication competent proviruses. Nature, 2017, Vol. 543, no. 7646, pp. 564-567.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">DiLillo D.J., Ravetch J.V. Differential Fc-receptor engagement drives an anti-tumor vaccinal effect. Cell, 2015, Vol. 161, no. 5, pp. 1035- 1045.</mixed-citation><mixed-citation xml:lang="en">DiLillo D.J., Ravetch J.V. Differential Fc-receptor engagement drives an anti-tumor vaccinal effect. Cell, 2015, Vol. 161, no. 5, pp. 1035- 1045.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Flinsenberg T.W., Janssen W.J., Herczenik E., Boross P., Nederend M., Jongeneel L.H., Scholman R.C., Boelens J.J., Maas C., van Gijn M.E., van Montfrans J.M., Leusen J.H., Boes M. A novel FcgammaRIIa Q27W gene variant is associated with common variable immune deficiency through defective FcgammaRIIa downstream signaling. Clin. Immunol., 2014, Vol. 155, no. 1, pp. 108-117.</mixed-citation><mixed-citation xml:lang="en">Flinsenberg T.W., Janssen W.J., Herczenik E., Boross P., Nederend M., Jongeneel L.H., Scholman R.C., Boelens J.J., Maas C., van Gijn M.E., van Montfrans J.M., Leusen J.H., Boes M. A novel FcgammaRIIa Q27W gene variant is associated with common variable immune deficiency through defective FcgammaRIIa downstream signaling. Clin. Immunol., 2014, Vol. 155, no. 1, pp. 108-117.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gan E.S., Ting D.H., Chan K.R. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Expert Rev. Anti Infect. Ther., 2017, Vol. 15, no. 2, pp. 111-119.</mixed-citation><mixed-citation xml:lang="en">Gan E.S., Ting D.H., Chan K.R. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Expert Rev. Anti Infect. Ther., 2017, Vol. 15, no. 2, pp. 111-119.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ganesan L.P., Fang H., Marsh C.B., Tridandapani S. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells. J. Biol. Chem., 2003, Vol. 278, no. 37, pp. 35710-35717.</mixed-citation><mixed-citation xml:lang="en">Ganesan L.P., Fang H., Marsh C.B., Tridandapani S. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells. J. Biol. Chem., 2003, Vol. 278, no. 37, pp. 35710-35717.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Getahun A., Cambier J.C. Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol. Rev., 2015, Vol. 268, no. 1, pp. 66-73.</mixed-citation><mixed-citation xml:lang="en">Getahun A., Cambier J.C. Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol. Rev., 2015, Vol. 268, no. 1, pp. 66-73.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Graziano R.F., Fanger M.W. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol., 1987, Vol. 139, no. 10, pp. 3536-3541.</mixed-citation><mixed-citation xml:lang="en">Graziano R.F., Fanger M.W. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol., 1987, Vol. 139, no. 10, pp. 3536-3541.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gul N., van Egmond M. Antibody-dependent phagocytosis of tumor cells by macrophages: a potent effector mechanism of monoclonal antibody therapy of cancer. Cancer Res., 2015, Vol. 75, no. 23, pp. 5008-5013.</mixed-citation><mixed-citation xml:lang="en">Gul N., van Egmond M. Antibody-dependent phagocytosis of tumor cells by macrophages: a potent effector mechanism of monoclonal antibody therapy of cancer. Cancer Res., 2015, Vol. 75, no. 23, pp. 5008-5013.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Guyre P.M., Morganelli P.M., Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest., 1983, Vol. 72, no. 1, pp. 393-397.</mixed-citation><mixed-citation xml:lang="en">Guyre P.M., Morganelli P.M., Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest., 1983, Vol. 72, no. 1, pp. 393-397.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol., 2002, Vol. 14, pp. 798-802.</mixed-citation><mixed-citation xml:lang="en">Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol., 2002, Vol. 14, pp. 798-802.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hogarth P.M., Anania J.C., Wines B.D. The FcgammaR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies. Curr. Top. Microbiol. Immunol., 2014, Vol. 382, pp. 321-352.</mixed-citation><mixed-citation xml:lang="en">Hogarth P.M., Anania J.C., Wines B.D. The FcgammaR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies. Curr. Top. Microbiol. Immunol., 2014, Vol. 382, pp. 321-352.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hogarth P.M., Pietersz G.A. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat. Rev. Drug Discov., 2012, Vol. 11, no. 4, pp. 311-331.</mixed-citation><mixed-citation xml:lang="en">Hogarth P.M., Pietersz G.A. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat. Rev. Drug Discov., 2012, Vol. 11, no. 4, pp. 311-331.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Holgado M.P., Sananez I., Raiden S., Geffner J.R., Arruvito L. CD32 ligation promotes the activation of CD4(+) T cells. Front. Immunol., 2018, Vol. 9, 2814. doi: 10.3389/fimmu.2018.02814</mixed-citation><mixed-citation xml:lang="en">Holgado M.P., Sananez I., Raiden S., Geffner J.R., Arruvito L. CD32 ligation promotes the activation of CD4(+) T cells. Front. Immunol., 2018, Vol. 9, 2814. doi: 10.3389/fimmu.2018.02814</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Hulett M.D., Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol., 1994, Vol. 57, pp. 1-127.</mixed-citation><mixed-citation xml:lang="en">Hulett M.D., Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol., 1994, Vol. 57, pp. 1-127.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Iglesias-Ussel M., Vandergeeten C., Marchionni L., Chomont N., Romerio F. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4 + T cells in virally suppressed subjects. J. Virol., 2013, Vol. 87, no. 16, pp. 9148-9158.</mixed-citation><mixed-citation xml:lang="en">Iglesias-Ussel M., Vandergeeten C., Marchionni L., Chomont N., Romerio F. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4 + T cells in virally suppressed subjects. J. Virol., 2013, Vol. 87, no. 16, pp. 9148-9158.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Karassa F.B., Bijl M., Davies K.A., Kallenberg C.G., Khamashta M.A., Manger K., Michel M., Piette J.-Ch., Salmon J.E., Song E.W., Tsuchiya N., Yoo D.-H., Ioannidiset J.P.A. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum., 2003, Vol. 48, no. 7, pp. 1930-1938.</mixed-citation><mixed-citation xml:lang="en">Karassa F.B., Bijl M., Davies K.A., Kallenberg C.G., Khamashta M.A., Manger K., Michel M., Piette J.-Ch., Salmon J.E., Song E.W., Tsuchiya N., Yoo D.-H., Ioannidiset J.P.A. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum., 2003, Vol. 48, no. 7, pp. 1930-1938.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Khor C.C., Davila S., Breunis W.B., Lee Y.C., Shimizu C., Wright V.J. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet., 2011, Vol. 43, no. 12, pp. 1241-1246.</mixed-citation><mixed-citation xml:lang="en">Khor C.C., Davila S., Breunis W.B., Lee Y.C., Shimizu C., Wright V.J. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet., 2011, Vol. 43, no. 12, pp. 1241-1246.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Krutmann J., Kirnbauer R., Kock A., Schwarz T., Schopf E., May L.T. Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation. J. Immunol., 1990, Vol. 145, no. 5, pp. 1337-1342.</mixed-citation><mixed-citation xml:lang="en">Krutmann J., Kirnbauer R., Kock A., Schwarz T., Schopf E., May L.T. Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation. J. Immunol., 1990, Vol. 145, no. 5, pp. 1337-1342.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo H.C., Hsu Y.W., Wu M.S., Woon P.Y., Wong H.S., Tsai L.J.FCGR2A promoter methylation and risks for intravenous immunoglobulin treatment responses in kawasaki disease. Mediators Inflamm., 2015, Vol. 2015, 564625. doi: 10.1155/2015/564625.</mixed-citation><mixed-citation xml:lang="en">Kuo H.C., Hsu Y.W., Wu M.S., Woon P.Y., Wong H.S., Tsai L.J.FCGR2A promoter methylation and risks for intravenous immunoglobulin treatment responses in kawasaki disease. Mediators Inflamm., 2015, Vol. 2015, 564625. doi: 10.1155/2015/564625.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lisi S., Sisto M., Lofrumento D.D., d’Amore S., d’Amore M. Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake. Clin. Exp. Med., 2011, Vol. 11, no. 1, pp. 1-10.</mixed-citation><mixed-citation xml:lang="en">Lisi S., Sisto M., Lofrumento D.D., d’Amore S., d’Amore M. Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake. Clin. Exp. Med., 2011, Vol. 11, no. 1, pp. 1-10.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Mkaddem S.B., Murua A., Flament H., Titeca-Beauport D., Bounaix C., Danelli L., Launay P., Benhamou M., Blank U., Daugas E., Charles N., Monteiro R.C. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat. Commun., 2017, Vol. 8, no. 1, 246. doi: 10.1038/s41467-017-00294-0.</mixed-citation><mixed-citation xml:lang="en">Mkaddem S.B., Murua A., Flament H., Titeca-Beauport D., Bounaix C., Danelli L., Launay P., Benhamou M., Blank U., Daugas E., Charles N., Monteiro R.C. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat. Commun., 2017, Vol. 8, no. 1, 246. doi: 10.1038/s41467-017-00294-0.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Nicu E.A., van der Velden U., Everts V., van Winkelhoff A.J., Roos D., Loos B.G. Hyper-reactive PMNs in FcgammaRIIa 131 H/H genotype periodontitis patients. J. Clin. Periodontol., 2007, Vol. 34, no. 11, pp. 938-945.</mixed-citation><mixed-citation xml:lang="en">Nicu E.A., van der Velden U., Everts V., van Winkelhoff A.J., Roos D., Loos B.G. Hyper-reactive PMNs in FcgammaRIIa 131 H/H genotype periodontitis patients. J. Clin. Periodontol., 2007, Vol. 34, no. 11, pp. 938-945.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Noto A., Procopio F.A., Banga R., Suffiotti M., Corpataux J.M., Cavassini M., Riva A., Fenwick C., Gottardo R., Perreau M., Pantaleo G. CD32(+) and PD-1(+) lymph node CD4 T cells support persistent HIV-1 transcription in treated aviremic individuals. J. Virol., 2018, Vol. 92, no. 20, e00901-18. doi: 10.1128/JVI.00901-18.</mixed-citation><mixed-citation xml:lang="en">Noto A., Procopio F.A., Banga R., Suffiotti M., Corpataux J.M., Cavassini M., Riva A., Fenwick C., Gottardo R., Perreau M., Pantaleo G. CD32(+) and PD-1(+) lymph node CD4 T cells support persistent HIV-1 transcription in treated aviremic individuals. J. Virol., 2018, Vol. 92, no. 20, e00901-18. doi: 10.1128/JVI.00901-18.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Osuna C.E., Lim S.Y., Kublin J.L., Apps R., Chen E., Mota T.M., Huang S.H., Ren Y., Bachtel N.D., Tsibris A.M., Ackerman M.E., Jones R.B., Nixon D.F., Whitneyet J.B. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature, 2018, Vol. 561, no. 7723, pp. e20-e28.</mixed-citation><mixed-citation xml:lang="en">Osuna C.E., Lim S.Y., Kublin J.L., Apps R., Chen E., Mota T.M., Huang S.H., Ren Y., Bachtel N.D., Tsibris A.M., Ackerman M.E., Jones R.B., Nixon D.F., Whitneyet J.B. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature, 2018, Vol. 561, no. 7723, pp. e20-e28.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Pathan N., Faust S.N., Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch. Dis. Child., 2003, Vol. 88, no. 7, pp. 601-607.</mixed-citation><mixed-citation xml:lang="en">Pathan N., Faust S.N., Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch. Dis. Child., 2003, Vol. 88, no. 7, pp. 601-607.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Perez L., Anderson J., Chipman J., Thorkelson A., Chun T.W., Moir S. Conflicting evidence for HIV enrichment in CD32(+) CD4 T cells. Nature, 2018, Vol. 561, no. 7723, pp. e9-e16.</mixed-citation><mixed-citation xml:lang="en">Perez L., Anderson J., Chipman J., Thorkelson A., Chun T.W., Moir S. Conflicting evidence for HIV enrichment in CD32(+) CD4 T cells. Nature, 2018, Vol. 561, no. 7723, pp. e9-e16.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Powell M.S., Barton P.A., Emmanouilidis D., Wines B.D., Neumann G.M., Peitersz G.A. Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for Ig. Immunol. Lett. G., 1999, Vol. 68, no. 1, pp. 17-23.</mixed-citation><mixed-citation xml:lang="en">Powell M.S., Barton P.A., Emmanouilidis D., Wines B.D., Neumann G.M., Peitersz G.A. Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for Ig. Immunol. Lett. G., 1999, Vol. 68, no. 1, pp. 17-23.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu W.Q., De Bruin D., Brownstein B.H., Pearse R., Ravetch J.V. Orgaization of the human and mouse lowaffinity FcγR genes: duplication an recombination. Science, 1990, Vol. 248, no. 4956, pp. 732-735.</mixed-citation><mixed-citation xml:lang="en">Qiu W.Q., De Bruin D., Brownstein B.H., Pearse R., Ravetch J.V. Orgaization of the human and mouse lowaffinity FcγR genes: duplication an recombination. Science, 1990, Vol. 248, no. 4956, pp. 732-735.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Raaz D., Herrmann M., Ekici A.B., Klinghammer L., Lausen B., Voll R.E., Leusen J.H., van de Winkel J.G., Daniel W.G., Reis A., Garlichs C.D. FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. Atherosclerosis, 2009, Vol. 205, no. 2, pp. 512-516.</mixed-citation><mixed-citation xml:lang="en">Raaz D., Herrmann M., Ekici A.B., Klinghammer L., Lausen B., Voll R.E., Leusen J.H., van de Winkel J.G., Daniel W.G., Reis A., Garlichs C.D. FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. Atherosclerosis, 2009, Vol. 205, no. 2, pp. 512-516.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Raaz-Schrauder D., Ekici A.B., Munoz L.E., Klinghammer L., Voll R.E., Leusen J.H., van de Winkel J.G., Reis A., Schett G., Garlichs C.D., Herrmann M. Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity, 2012, Vol. 45, no. 7, pp. 556-564.</mixed-citation><mixed-citation xml:lang="en">Raaz-Schrauder D., Ekici A.B., Munoz L.E., Klinghammer L., Voll R.E., Leusen J.H., van de Winkel J.G., Reis A., Schett G., Garlichs C.D., Herrmann M. Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity, 2012, Vol. 45, no. 7, pp. 556-564.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez M.E., van der Pol W.L., Sanders L.A., van de Winkel J.G. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J. Infect. Dis., 1999, Vol. 179, no. 2, pp. 423-433.</mixed-citation><mixed-citation xml:lang="en">Rodriguez M.E., van der Pol W.L., Sanders L.A., van de Winkel J.G. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J. Infect. Dis., 1999, Vol. 179, no. 2, pp. 423-433.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 1994, Vol. 179, no. 4, pp. 1109-1118.</mixed-citation><mixed-citation xml:lang="en">Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 1994, Vol. 179, no. 4, pp. 1109-1118.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Shushakova N., Skokowa J., Schulman J., Baumann U., Zwirner J., Schmidt R.E., Gessner J.E. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J. Clin. Invest., 2002, Vol. 110, no. 12, pp. 1823-1830.</mixed-citation><mixed-citation xml:lang="en">Shushakova N., Skokowa J., Schulman J., Baumann U., Zwirner J., Schmidt R.E., Gessner J.E. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J. Clin. Invest., 2002, Vol. 110, no. 12, pp. 1823-1830.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Simms H.H., Gaither T.A., Fries L.F., Frank M.M. Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function. J. Immunol., 1991, Vol. 147, no. 1, pp. 265-272.</mixed-citation><mixed-citation xml:lang="en">Simms H.H., Gaither T.A., Fries L.F., Frank M.M. Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function. J. Immunol., 1991, Vol. 147, no. 1, pp. 265-272.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">te Velde A.A., de Waal Malefijt R., Huijbens R.J., de Vries J.E., Figdor C.G. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J. Immunol., 1992, Vol. 149, no. 12, pp. 4048-4052.</mixed-citation><mixed-citation xml:lang="en">te Velde A.A., de Waal Malefijt R., Huijbens R.J., de Vries J.E., Figdor C.G. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J. Immunol., 1992, Vol. 149, no. 12, pp. 4048-4052.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Trist H.M., Tan P.S., Wines B.D., Ramsland P.A., Orlowski E., Stubbs J., Gardiner E.E., Pietersz G.A., Kent S.J., Stratov I., Burton D.R., Hogarth P.M. Polymorphisms and interspecies differences of the activating and inhibitory FcgammaRII of Macaca nemestrina influence the binding of human IgG subclasses. J. Immunol., 2014, Vol. 192, no. 2, 792-803.</mixed-citation><mixed-citation xml:lang="en">Trist H.M., Tan P.S., Wines B.D., Ramsland P.A., Orlowski E., Stubbs J., Gardiner E.E., Pietersz G.A., Kent S.J., Stratov I., Burton D.R., Hogarth P.M. Polymorphisms and interspecies differences of the activating and inhibitory FcgammaRII of Macaca nemestrina influence the binding of human IgG subclasses. J. Immunol., 2014, Vol. 192, no. 2, 792-803.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">van der Heijden J., Geissler J., van Mirre E., van Deuren M.J., van der Meer W., Salama A.T.K., van den Berg T.K., Roos D., Kuijpers T.W. A novel splice variant of FcgammaRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia. J. Allergy Clin. Immunol., 2013, Vol. 131, no. 5, pp. 1408-1416.</mixed-citation><mixed-citation xml:lang="en">van der Heijden J., Geissler J., van Mirre E., van Deuren M.J., van der Meer W., Salama A.T.K., van den Berg T.K., Roos D., Kuijpers T.W. A novel splice variant of FcgammaRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia. J. Allergy Clin. Immunol., 2013, Vol. 131, no. 5, pp. 1408-1416.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">van der Pol W.L., van den Berg L.H., Scheepers R.H. van der Bom J.G., van Doorn P.A., van Koningsveld R. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. Neurology, 2000, Vol. 54, no. 8, pp. 1661-1665.</mixed-citation><mixed-citation xml:lang="en">van der Pol W.L., van den Berg L.H., Scheepers R.H. van der Bom J.G., van Doorn P.A., van Koningsveld R. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. Neurology, 2000, Vol. 54, no. 8, pp. 1661-1665.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Vasquez J.J., Aguilar-Rodriguez B.L., Rodriguez L., Hogan L.E., Somsouk M., McCune J.M. CD32-RNA co-localizes with HIV-RNA in CD3 + cells found within gut tissues from viremic and ART-suppressed individuals. Pathog. Immun., 2019, Vol. 4, no. 1, pp. 147-160.</mixed-citation><mixed-citation xml:lang="en">Vasquez J.J., Aguilar-Rodriguez B.L., Rodriguez L., Hogan L.E., Somsouk M., McCune J.M. CD32-RNA co-localizes with HIV-RNA in CD3 + cells found within gut tissues from viremic and ART-suppressed individuals. Pathog. Immun., 2019, Vol. 4, no. 1, pp. 147-160.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Vogelpoel L.T., Baeten D.L., de Jong E.C., den Dunnen J. Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front. Immunol., 2015, Vol. 6, 79. doi: 10.3389/fimmu.2015.00079</mixed-citation><mixed-citation xml:lang="en">Vogelpoel L.T., Baeten D.L., de Jong E.C., den Dunnen J. Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front. Immunol., 2015, Vol. 6, 79. doi: 10.3389/fimmu.2015.00079</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace P.K., Tsang K.Y., Goldstein J., Correale P., Jarry T.M., Schlom J. Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J. Immunol. Methods, 2001, Vol. 248, no. 1-2, pp. 183-194.</mixed-citation><mixed-citation xml:lang="en">Wallace P.K., Tsang K.Y., Goldstein J., Correale P., Jarry T.M., Schlom J. Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J. Immunol. Methods, 2001, Vol. 248, no. 1-2, pp. 183-194.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">White J.G., Clawson C.C. Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Ultrastruct. Pathol., 1981, Vol. 2, no. 3, pp. 277-287.</mixed-citation><mixed-citation xml:lang="en">White J.G., Clawson C.C. Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Ultrastruct. Pathol., 1981, Vol. 2, no. 3, pp. 277-287.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Worth R.G., Chien C.D., Chien P., Reilly M.P., McKenzie S.E., Schreiber A.D. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp. Hematol., 2006, Vol. 34, no. 11, pp. 1490-1495.</mixed-citation><mixed-citation xml:lang="en">Worth R.G., Chien C.D., Chien P., Reilly M.P., McKenzie S.E., Schreiber A.D. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp. Hematol., 2006, Vol. 34, no. 11, pp. 1490-1495.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan F.F., Wong M., Pererva N., Keating J., Davis A.R., Bryant J.A., Sullivan J.S. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol., 2003, Vol. 81, no. 3, pp. 192-195.</mixed-citation><mixed-citation xml:lang="en">Yuan F.F., Wong M., Pererva N., Keating J., Davis A.R., Bryant J.A., Sullivan J.S. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol., 2003, Vol. 81, no. 3, pp. 192-195.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
